Table 3.
Regression Coefficient | 95% CI | P Value | |
---|---|---|---|
Pp65‐specific IFN‐γ secretion (R 2=0.519) | |||
Age, y | 0.004 | 0.004 to 0.005 | <0.001 |
Female sex | −0.021 | −0.039 to −0.002 | 0.031 |
DM history | 0.026 | 0.010 to 0.042 | 0.001 |
Smoking history | 0.009 | −0.003 to 0.021 | 0.161 |
BMI, kg/m2 | −0.002 | −0.005 to 0.000 | 0.067 |
SBP, mm Hg | 0.002 | 0.001 to 0.002 | <0.001 |
Creatinine, mg/dL | 0.003 | −0.008 to 0.014 | 0.579 |
HDL‐cholesterol, mg/dL | 0.000 | −0.001 to 0.000 | 0.237 |
hsCRP, mg/L | 0.001 | −0.001 to 0.003 | 0.361 |
Percent IFN‐γ+ in CD8+ T cellsa | 0.020 | 0.007 to 0.033 | 0.003 |
pp65‐specific TNF‐α secretion (R 2=0.517) | |||
Age, y | 0.004 | 0.004 to 0.005 | <0.001 |
Female sex | −0.021 | −0.040 to −0.002 | 0.030 |
DM history | 0.025 | 0.010 to 0.041 | 0.002 |
Smoking history | 0.008 | −0.004 to 0.021 | 0.181 |
BMI, kg/m2 | −0.002 | −0.005 to 0.000 | 0.084 |
SBP, mm Hg | 0.002 | 0.001 to 0.002 | <0.001 |
Creatinine, mg/dL | 0.004 | −0.007 to 0.015 | 0.453 |
HDL‐cholesterol, mg/dL | 0.000 | −0.001 to 0.000 | 0.256 |
hsCRP, mg/L | 0.001 | −0.001 to 0.003 | 0.351 |
Percent TNF‐α+ in CD8+ T cellsa | 0.021 | 0.006 to 0.036 | 0.006 |
Pp65‐specific CD107a expression (R 2=0.517) | |||
Age, y | 0.004 | 0.003 to 0.005 | <0.001 |
Female sex | −0.021 | −0.040 to −0.002 | 0.027 |
DM history | 0.027 | 0.011 to 0.043 | 0.001 |
Smoking history | 0.009 | −0.004 to 0.021 | 0.174 |
BMI, kg/m2 | −0.002 | −0.004 to 0.000 | 0.116 |
SBP, mm Hg | 0.002 | 0.001 to 0.002 | <0.001 |
Creatinine, mg/dL | 0.004 | −0.007 to 0.015 | 0.466 |
HDL‐cholesterol, mg/dL | 0.000 | −0.001 to 0.000 | 0.330 |
hsCRP, mg/L | 0.001 | −0.001 to 0.003 | 0.314 |
Percent CD107a+ in CD8+ T cellsa | 0.033 | 0.010 to 0.056 | 0.006 |
BMI indicates body mass index; CI, confidence interval; DM, diabetes mellitus; HDL, high‐density lipoprotein; hsCRP, high‐sensitivity C‐reactive protein; IFN‐γ, interferon‐γ; PWV, pulse wave velocity; SBP, systolic blood pressure; TNF‐α, tumor necrosis factor‐α.
Log‐transformed.